Click for best price
Selfadministered Parenteral Market Size, Share 2024
This research report provides a comprehensive analysis of the Self-administered Parenteral market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Self-administered Parenteral market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Self-administered Parenteral, challenges faced by the industry, and potential opportunities for market players.
The global Self-administered Parenteral market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Self-administered Parenteral market presents opportunities for various stakeholders, including Pharmacy, Online Sales. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Self-administered Parenteral market. Additionally, the growing consumer demand present avenues for market expansion.
The global Self-administered Parenteral market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
Key Features:
The research report on the Self-administered Parenteral market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Self-administered Parenteral market.
Market Overview: The report provides a comprehensive overview of the Self-administered Parenteral market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Pre-filled Syringes, Autoinjectors), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Self-administered Parenteral market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Self-administered Parenteral market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Self-administered Parenteral market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Self-administered Parenteral market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Self-administered Parenteral market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Self-administered Parenteral market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Self-administered Parenteral, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Self-administered Parenteral market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Self-administered Parenteral market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Pre-filled Syringes
Autoinjectors
Pen Injectors
Others
Market segment by Application
Pharmacy
Online Sales
Other
Global Self-administered Parenteral Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Becton, Dickinson and Company
scPharmaceuticals
Harro Hofliger
Owen Mumford
Haselmeier
Stevanato Group
Ypsomed AG
Solteam Group
AstraZeneca
Enable lnjections
CCBio
Phillips-Medisize Corporation
Sorrel Medical
Krontec Healthcare
Subcuject Aps
Ascendia Pharmaceuticals
West Pharmaceutical Services, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Self-administered Parenteral, market overview.
Chapter 2: Global Self-administered Parenteral market size in revenue and volume.
Chapter 3: Detailed analysis of Self-administered Parenteral manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Self-administered Parenteral in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Self-administered Parenteral capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Self-administered Parenteral Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
140 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Self-administered Parenteral Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Self-administered Parenteral Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Self-administered Parenteral Overall Market Size
2.1 Global Self-administered Parenteral Market Size: 2023 VS 2030
2.2 Global Self-administered Parenteral Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Self-administered Parenteral Sales: 2019-2030
3 Company Landscape
3.1 Top Self-administered Parenteral Players in Global Market
3.2 Top Global Self-administered Parenteral Companies Ranked by Revenue
3.3 Global Self-administered Parenteral Revenue by Companies
3.4 Global Self-administered Parenteral Sales by Companies
3.5 Global Self-administered Parenteral Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Self-administered Parenteral Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Self-administered Parenteral Product Type
3.8 Tier 1, Tier 2 and Tier 3 Self-administered Parenteral Players in Global Market
3.8.1 List of Global Tier 1 Self-administered Parenteral Companies
3.8.2 List of Global Tier 2 and Tier 3 Self-administered Parenteral Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Self-administered Parenteral Market Size Markets, 2023 & 2030
4.1.2 Pre-filled Syringes
4.1.3 Autoinjectors
4.1.4 Pen Injectors
4.1.5 Others
4.2 By Type - Global Self-administered Parenteral Revenue & Forecasts
4.2.1 By Type - Global Self-administered Parenteral Revenue, 2019-2024
4.2.2 By Type - Global Self-administered Parenteral Revenue, 2025-2030
4.2.3 By Type - Global Self-administered Parenteral Revenue Market Share, 2019-2030
4.3 By Type - Global Self-administered Parenteral Sales & Forecasts
4.3.1 By Type - Global Self-administered Parenteral Sales, 2019-2024
4.3.2 By Type - Global Self-administered Parenteral Sales, 2025-2030
4.3.3 By Type - Global Self-administered Parenteral Sales Market Share, 2019-2030
4.4 By Type - Global Self-administered Parenteral Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Self-administered Parenteral Market Size, 2023 & 2030
5.1.2 Pharmacy
5.1.3 Online Sales
5.1.4 Other
5.2 By Application - Global Self-administered Parenteral Revenue & Forecasts
5.2.1 By Application - Global Self-administered Parenteral Revenue, 2019-2024
5.2.2 By Application - Global Self-administered Parenteral Revenue, 2025-2030
5.2.3 By Application - Global Self-administered Parenteral Revenue Market Share, 2019-2030
5.3 By Application - Global Self-administered Parenteral Sales & Forecasts
5.3.1 By Application - Global Self-administered Parenteral Sales, 2019-2024
5.3.2 By Application - Global Self-administered Parenteral Sales, 2025-2030
5.3.3 By Application - Global Self-administered Parenteral Sales Market Share, 2019-2030
5.4 By Application - Global Self-administered Parenteral Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Self-administered Parenteral Market Size, 2023 & 2030
6.2 By Region - Global Self-administered Parenteral Revenue & Forecasts
6.2.1 By Region - Global Self-administered Parenteral Revenue, 2019-2024
6.2.2 By Region - Global Self-administered Parenteral Revenue, 2025-2030
6.2.3 By Region - Global Self-administered Parenteral Revenue Market Share, 2019-2030
6.3 By Region - Global Self-administered Parenteral Sales & Forecasts
6.3.1 By Region - Global Self-administered Parenteral Sales, 2019-2024
6.3.2 By Region - Global Self-administered Parenteral Sales, 2025-2030
6.3.3 By Region - Global Self-administered Parenteral Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Self-administered Parenteral Revenue, 2019-2030
6.4.2 By Country - North America Self-administered Parenteral Sales, 2019-2030
6.4.3 US Self-administered Parenteral Market Size, 2019-2030
6.4.4 Canada Self-administered Parenteral Market Size, 2019-2030
6.4.5 Mexico Self-administered Parenteral Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Self-administered Parenteral Revenue, 2019-2030
6.5.2 By Country - Europe Self-administered Parenteral Sales, 2019-2030
6.5.3 Germany Self-administered Parenteral Market Size, 2019-2030
6.5.4 France Self-administered Parenteral Market Size, 2019-2030
6.5.5 U.K. Self-administered Parenteral Market Size, 2019-2030
6.5.6 Italy Self-administered Parenteral Market Size, 2019-2030
6.5.7 Russia Self-administered Parenteral Market Size, 2019-2030
6.5.8 Nordic Countries Self-administered Parenteral Market Size, 2019-2030
6.5.9 Benelux Self-administered Parenteral Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Self-administered Parenteral Revenue, 2019-2030
6.6.2 By Region - Asia Self-administered Parenteral Sales, 2019-2030
6.6.3 China Self-administered Parenteral Market Size, 2019-2030
6.6.4 Japan Self-administered Parenteral Market Size, 2019-2030
6.6.5 South Korea Self-administered Parenteral Market Size, 2019-2030
6.6.6 Southeast Asia Self-administered Parenteral Market Size, 2019-2030
6.6.7 India Self-administered Parenteral Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Self-administered Parenteral Revenue, 2019-2030
6.7.2 By Country - South America Self-administered Parenteral Sales, 2019-2030
6.7.3 Brazil Self-administered Parenteral Market Size, 2019-2030
6.7.4 Argentina Self-administered Parenteral Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Self-administered Parenteral Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Self-administered Parenteral Sales, 2019-2030
6.8.3 Turkey Self-administered Parenteral Market Size, 2019-2030
6.8.4 Israel Self-administered Parenteral Market Size, 2019-2030
6.8.5 Saudi Arabia Self-administered Parenteral Market Size, 2019-2030
6.8.6 UAE Self-administered Parenteral Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Becton, Dickinson and Company
7.1.1 Becton, Dickinson and Company Company Summary
7.1.2 Becton, Dickinson and Company Business Overview
7.1.3 Becton, Dickinson and Company Self-administered Parenteral Major Product Offerings
7.1.4 Becton, Dickinson and Company Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.1.5 Becton, Dickinson and Company Key News & Latest Developments
7.2 scPharmaceuticals
7.2.1 scPharmaceuticals Company Summary
7.2.2 scPharmaceuticals Business Overview
7.2.3 scPharmaceuticals Self-administered Parenteral Major Product Offerings
7.2.4 scPharmaceuticals Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.2.5 scPharmaceuticals Key News & Latest Developments
7.3 Harro Hofliger
7.3.1 Harro Hofliger Company Summary
7.3.2 Harro Hofliger Business Overview
7.3.3 Harro Hofliger Self-administered Parenteral Major Product Offerings
7.3.4 Harro Hofliger Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.3.5 Harro Hofliger Key News & Latest Developments
7.4 Owen Mumford
7.4.1 Owen Mumford Company Summary
7.4.2 Owen Mumford Business Overview
7.4.3 Owen Mumford Self-administered Parenteral Major Product Offerings
7.4.4 Owen Mumford Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.4.5 Owen Mumford Key News & Latest Developments
7.5 Haselmeier
7.5.1 Haselmeier Company Summary
7.5.2 Haselmeier Business Overview
7.5.3 Haselmeier Self-administered Parenteral Major Product Offerings
7.5.4 Haselmeier Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.5.5 Haselmeier Key News & Latest Developments
7.6 Stevanato Group
7.6.1 Stevanato Group Company Summary
7.6.2 Stevanato Group Business Overview
7.6.3 Stevanato Group Self-administered Parenteral Major Product Offerings
7.6.4 Stevanato Group Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.6.5 Stevanato Group Key News & Latest Developments
7.7 Ypsomed AG
7.7.1 Ypsomed AG Company Summary
7.7.2 Ypsomed AG Business Overview
7.7.3 Ypsomed AG Self-administered Parenteral Major Product Offerings
7.7.4 Ypsomed AG Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.7.5 Ypsomed AG Key News & Latest Developments
7.8 Solteam Group
7.8.1 Solteam Group Company Summary
7.8.2 Solteam Group Business Overview
7.8.3 Solteam Group Self-administered Parenteral Major Product Offerings
7.8.4 Solteam Group Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.8.5 Solteam Group Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Self-administered Parenteral Major Product Offerings
7.9.4 AstraZeneca Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 Enable lnjections
7.10.1 Enable lnjections Company Summary
7.10.2 Enable lnjections Business Overview
7.10.3 Enable lnjections Self-administered Parenteral Major Product Offerings
7.10.4 Enable lnjections Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.10.5 Enable lnjections Key News & Latest Developments
7.11 CCBio
7.11.1 CCBio Company Summary
7.11.2 CCBio Business Overview
7.11.3 CCBio Self-administered Parenteral Major Product Offerings
7.11.4 CCBio Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.11.5 CCBio Key News & Latest Developments
7.12 Phillips-Medisize Corporation
7.12.1 Phillips-Medisize Corporation Company Summary
7.12.2 Phillips-Medisize Corporation Business Overview
7.12.3 Phillips-Medisize Corporation Self-administered Parenteral Major Product Offerings
7.12.4 Phillips-Medisize Corporation Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.12.5 Phillips-Medisize Corporation Key News & Latest Developments
7.13 Sorrel Medical
7.13.1 Sorrel Medical Company Summary
7.13.2 Sorrel Medical Business Overview
7.13.3 Sorrel Medical Self-administered Parenteral Major Product Offerings
7.13.4 Sorrel Medical Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.13.5 Sorrel Medical Key News & Latest Developments
7.14 Krontec Healthcare
7.14.1 Krontec Healthcare Company Summary
7.14.2 Krontec Healthcare Business Overview
7.14.3 Krontec Healthcare Self-administered Parenteral Major Product Offerings
7.14.4 Krontec Healthcare Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.14.5 Krontec Healthcare Key News & Latest Developments
7.15 Subcuject Aps
7.15.1 Subcuject Aps Company Summary
7.15.2 Subcuject Aps Business Overview
7.15.3 Subcuject Aps Self-administered Parenteral Major Product Offerings
7.15.4 Subcuject Aps Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.15.5 Subcuject Aps Key News & Latest Developments
7.16 Ascendia Pharmaceuticals
7.16.1 Ascendia Pharmaceuticals Company Summary
7.16.2 Ascendia Pharmaceuticals Business Overview
7.16.3 Ascendia Pharmaceuticals Self-administered Parenteral Major Product Offerings
7.16.4 Ascendia Pharmaceuticals Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.16.5 Ascendia Pharmaceuticals Key News & Latest Developments
7.17 West Pharmaceutical Services, Inc.
7.17.1 West Pharmaceutical Services, Inc. Company Summary
7.17.2 West Pharmaceutical Services, Inc. Business Overview
7.17.3 West Pharmaceutical Services, Inc. Self-administered Parenteral Major Product Offerings
7.17.4 West Pharmaceutical Services, Inc. Self-administered Parenteral Sales and Revenue in Global (2019-2024)
7.17.5 West Pharmaceutical Services, Inc. Key News & Latest Developments
8 Global Self-administered Parenteral Production Capacity, Analysis
8.1 Global Self-administered Parenteral Production Capacity, 2019-2030
8.2 Self-administered Parenteral Production Capacity of Key Manufacturers in Global Market
8.3 Global Self-administered Parenteral Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Self-administered Parenteral Supply Chain Analysis
10.1 Self-administered Parenteral Industry Value Chain
10.2 Self-administered Parenteral Upstream Market
10.3 Self-administered Parenteral Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Self-administered Parenteral Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Self-administered Parenteral in Global Market
Table 2. Top Self-administered Parenteral Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Self-administered Parenteral Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Self-administered Parenteral Revenue Share by Companies, 2019-2024
Table 5. Global Self-administered Parenteral Sales by Companies, (K Units), 2019-2024
Table 6. Global Self-administered Parenteral Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Self-administered Parenteral Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Self-administered Parenteral Product Type
Table 9. List of Global Tier 1 Self-administered Parenteral Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Self-administered Parenteral Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Self-administered Parenteral Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Self-administered Parenteral Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Self-administered Parenteral Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Self-administered Parenteral Sales (K Units), 2019-2024
Table 15. By Type - Global Self-administered Parenteral Sales (K Units), 2025-2030
Table 16. By Application ? Global Self-administered Parenteral Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Self-administered Parenteral Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Self-administered Parenteral Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Self-administered Parenteral Sales (K Units), 2019-2024
Table 20. By Application - Global Self-administered Parenteral Sales (K Units), 2025-2030
Table 21. By Region ? Global Self-administered Parenteral Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Self-administered Parenteral Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Self-administered Parenteral Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Self-administered Parenteral Sales (K Units), 2019-2024
Table 25. By Region - Global Self-administered Parenteral Sales (K Units), 2025-2030
Table 26. By Country - North America Self-administered Parenteral Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Self-administered Parenteral Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Self-administered Parenteral Sales, (K Units), 2019-2024
Table 29. By Country - North America Self-administered Parenteral Sales, (K Units), 2025-2030
Table 30. By Country - Europe Self-administered Parenteral Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Self-administered Parenteral Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Self-administered Parenteral Sales, (K Units), 2019-2024
Table 33. By Country - Europe Self-administered Parenteral Sales, (K Units), 2025-2030
Table 34. By Region - Asia Self-administered Parenteral Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Self-administered Parenteral Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Self-administered Parenteral Sales, (K Units), 2019-2024
Table 37. By Region - Asia Self-administered Parenteral Sales, (K Units), 2025-2030
Table 38. By Country - South America Self-administered Parenteral Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Self-administered Parenteral Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Self-administered Parenteral Sales, (K Units), 2019-2024
Table 41. By Country - South America Self-administered Parenteral Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Self-administered Parenteral Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Self-administered Parenteral Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Self-administered Parenteral Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Self-administered Parenteral Sales, (K Units), 2025-2030
Table 46. Becton, Dickinson and Company Company Summary
Table 47. Becton, Dickinson and Company Self-administered Parenteral Product Offerings
Table 48. Becton, Dickinson and Company Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Becton, Dickinson and Company Key News & Latest Developments
Table 50. scPharmaceuticals Company Summary
Table 51. scPharmaceuticals Self-administered Parenteral Product Offerings
Table 52. scPharmaceuticals Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. scPharmaceuticals Key News & Latest Developments
Table 54. Harro Hofliger Company Summary
Table 55. Harro Hofliger Self-administered Parenteral Product Offerings
Table 56. Harro Hofliger Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Harro Hofliger Key News & Latest Developments
Table 58. Owen Mumford Company Summary
Table 59. Owen Mumford Self-administered Parenteral Product Offerings
Table 60. Owen Mumford Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Owen Mumford Key News & Latest Developments
Table 62. Haselmeier Company Summary
Table 63. Haselmeier Self-administered Parenteral Product Offerings
Table 64. Haselmeier Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Haselmeier Key News & Latest Developments
Table 66. Stevanato Group Company Summary
Table 67. Stevanato Group Self-administered Parenteral Product Offerings
Table 68. Stevanato Group Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Stevanato Group Key News & Latest Developments
Table 70. Ypsomed AG Company Summary
Table 71. Ypsomed AG Self-administered Parenteral Product Offerings
Table 72. Ypsomed AG Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Ypsomed AG Key News & Latest Developments
Table 74. Solteam Group Company Summary
Table 75. Solteam Group Self-administered Parenteral Product Offerings
Table 76. Solteam Group Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Solteam Group Key News & Latest Developments
Table 78. AstraZeneca Company Summary
Table 79. AstraZeneca Self-administered Parenteral Product Offerings
Table 80. AstraZeneca Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. AstraZeneca Key News & Latest Developments
Table 82. Enable lnjections Company Summary
Table 83. Enable lnjections Self-administered Parenteral Product Offerings
Table 84. Enable lnjections Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Enable lnjections Key News & Latest Developments
Table 86. CCBio Company Summary
Table 87. CCBio Self-administered Parenteral Product Offerings
Table 88. CCBio Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. CCBio Key News & Latest Developments
Table 90. Phillips-Medisize Corporation Company Summary
Table 91. Phillips-Medisize Corporation Self-administered Parenteral Product Offerings
Table 92. Phillips-Medisize Corporation Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Phillips-Medisize Corporation Key News & Latest Developments
Table 94. Sorrel Medical Company Summary
Table 95. Sorrel Medical Self-administered Parenteral Product Offerings
Table 96. Sorrel Medical Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Sorrel Medical Key News & Latest Developments
Table 98. Krontec Healthcare Company Summary
Table 99. Krontec Healthcare Self-administered Parenteral Product Offerings
Table 100. Krontec Healthcare Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Krontec Healthcare Key News & Latest Developments
Table 102. Subcuject Aps Company Summary
Table 103. Subcuject Aps Self-administered Parenteral Product Offerings
Table 104. Subcuject Aps Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Subcuject Aps Key News & Latest Developments
Table 106. Ascendia Pharmaceuticals Company Summary
Table 107. Ascendia Pharmaceuticals Self-administered Parenteral Product Offerings
Table 108. Ascendia Pharmaceuticals Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 109. Ascendia Pharmaceuticals Key News & Latest Developments
Table 110. West Pharmaceutical Services, Inc. Company Summary
Table 111. West Pharmaceutical Services, Inc. Self-administered Parenteral Product Offerings
Table 112. West Pharmaceutical Services, Inc. Self-administered Parenteral Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 113. West Pharmaceutical Services, Inc. Key News & Latest Developments
Table 114. Self-administered Parenteral Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 115. Global Self-administered Parenteral Capacity Market Share of Key Manufacturers, 2022-2024
Table 116. Global Self-administered Parenteral Production by Region, 2019-2024 (K Units)
Table 117. Global Self-administered Parenteral Production by Region, 2025-2030 (K Units)
Table 118. Self-administered Parenteral Market Opportunities & Trends in Global Market
Table 119. Self-administered Parenteral Market Drivers in Global Market
Table 120. Self-administered Parenteral Market Restraints in Global Market
Table 121. Self-administered Parenteral Raw Materials
Table 122. Self-administered Parenteral Raw Materials Suppliers in Global Market
Table 123. Typical Self-administered Parenteral Downstream
Table 124. Self-administered Parenteral Downstream Clients in Global Market
Table 125. Self-administered Parenteral Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Self-administered Parenteral Segment by Type in 2023
Figure 2. Self-administered Parenteral Segment by Application in 2023
Figure 3. Global Self-administered Parenteral Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Self-administered Parenteral Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Self-administered Parenteral Revenue, 2019-2030 (US$, Mn)
Figure 7. Self-administered Parenteral Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Self-administered Parenteral Revenue in 2023
Figure 9. By Type - Global Self-administered Parenteral Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Self-administered Parenteral Revenue Market Share, 2019-2030
Figure 11. By Type - Global Self-administered Parenteral Sales Market Share, 2019-2030
Figure 12. By Type - Global Self-administered Parenteral Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Self-administered Parenteral Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Self-administered Parenteral Revenue Market Share, 2019-2030
Figure 15. By Application - Global Self-administered Parenteral Sales Market Share, 2019-2030
Figure 16. By Application - Global Self-administered Parenteral Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Self-administered Parenteral Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Self-administered Parenteral Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Self-administered Parenteral Revenue Market Share, 2019-2030
Figure 20. By Region - Global Self-administered Parenteral Sales Market Share, 2019-2030
Figure 21. By Country - North America Self-administered Parenteral Revenue Market Share, 2019-2030
Figure 22. By Country - North America Self-administered Parenteral Sales Market Share, 2019-2030
Figure 23. US Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Self-administered Parenteral Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Self-administered Parenteral Sales Market Share, 2019-2030
Figure 28. Germany Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 29. France Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Self-administered Parenteral Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Self-administered Parenteral Sales Market Share, 2019-2030
Figure 37. China Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 41. India Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Self-administered Parenteral Revenue Market Share, 2019-2030
Figure 43. By Country - South America Self-administered Parenteral Sales Market Share, 2019-2030
Figure 44. Brazil Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Self-administered Parenteral Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Self-administered Parenteral Sales Market Share, 2019-2030
Figure 48. Turkey Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Self-administered Parenteral Revenue, (US$, Mn), 2019-2030
Figure 52. Global Self-administered Parenteral Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Self-administered Parenteral by Region, 2023 VS 2030
Figure 54. Self-administered Parenteral Industry Value Chain
Figure 55. Marketing Channels
